ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,558Medicare Part D Prescriptions Filled, Including Refills

Rank: 339 out of 2888

$1.16M Total Retail Price of All Prescriptions

Rank: 149 out of 2888

732 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
12% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 732 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,221 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 567 530 1 1
SIMVASTATIN 437 393 2 2
AMLODIPINE BESYLATE 376 362 3 5
ATORVASTATIN CALCIUM 343 312 4 9
CRESTOR 325 320 5 20
LISINOPRIL 304 258 6 3
METFORMIN HCL 301 255 7 8
OMEPRAZOLE 276 212 8 7
METOPROLOL SUCCINATE 267 261 9 11
ALENDRONATE SODIUM 232 226 10 23
FENOFIBRATE 222 201 11 65
WARFARIN SODIUM 196 184 12 22
LOSARTAN POTASSIUM 185 179 13 18
HYDROCODONE-ACETAMINOPHEN 184 139 S3 14 4
HYDROCHLOROTHIAZIDE 184 168 14 15
CARVEDILOL 177 140 16 21
ZOLPIDEM TARTRATE 176 143 17 17
POTASSIUM CHLORIDE 170 148 18 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 141 19 28
FLUTICASONE PROPIONATE 163 142 20 32
FUROSEMIDE 160 128 21 6
ZETIA 160 149 21 81
CITALOPRAM HBR 154 117 23 24
NEXIUM 142 109 24 19
PRAVASTATIN SODIUM 141 130 25 12
DIOVAN HCT 125 119 26 61
LIPITOR 122 115 27 78
METOPROLOL TARTRATE 112 104 28 10
TRAMADOL HCL 101 83 29 16
GABAPENTIN 100 66 30 13
TRAMADOL HCL-ACETAMINOPHEN 97 92 31 95
TRIAMTERENE-HCTZ 95 85 32 63
ALLOPURINOL 94 88 33 37
PANTOPRAZOLE SODIUM 89 87 34 33
TAMSULOSIN HCL 89 86 34 29
CLONIDINE HCL 87 85 36 39
ATENOLOL 87 83 36 25
FLUOXETINE HCL 87 68 36 83
GLIMEPIRIDE 86 81 39 36
DIOVAN 85 80 40 35
SERTRALINE HCL 85 81 40 27
CLOPIDOGREL 82 82 42 30
PREMARIN 80 78 R 43 129
AMLODIPINE BESYLATE-BENAZEPRIL 79 67 44 67
AMITRIPTYLINE HCL 75 62 R 45 74
MELOXICAM 74 66 46 31
PLAVIX 72 72 47 40
METFORMIN HCL ER 66 64 48 53
DIGOXIN 64 52 49 55
PREDNISONE 63 49 50 42
CYMBALTA 62 52 51 44
PEN NEEDLE 59 48 52 110
SYNTHROID 58 58 53 52
SPIRIVA 55 55 54 79
LOVASTATIN 52 52 55 41
CIPROFLOXACIN HCL 51 45 56 47
VESICARE 51 45 56 154
DONEPEZIL HCL 51 51 56 26
FELODIPINE ER 51 43 56 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.